Evaluating effects of treatment in subgroups of patients within a clinical trial: The case of non-Q-wave myocardial infarction and beta blockers
- 15 July 1990
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (2) , 220-222
- https://doi.org/10.1016/0002-9149(90)90592-o
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Empirical Bayes estimates of subgroup effects in clinical trialsControlled Clinical Trials, 1990
- Overview of Results of Randomized Clinical Trials in Heart DiseasePublished by American Medical Association (AMA) ,1988
- Overview of Results of Randomized Clinical Trials in Heart DiseaseJAMA, 1988
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- Why do we need some large, simple randomized trials?Statistics in Medicine, 1984
- A Randomized Trial of Propranolol in Patients With Acute Myocardial InfarctionJAMA, 1982
- EFFECT OF ALPRENOLOL ON MORTALITY AMONG PATIENTS WITH DEFINITE OR SUSPECTED ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1979
- Reduction in mortality after myocardial infarction with long-term beta-adrenoceptor blockade. Multicentre international study: supplementary report.BMJ, 1977